Berkshire earnings rose last quarter and CEO Greg Abel is starting to deploy Buffett's massive cash hoard

Berkshire Hathaway’s Q2 operating earnings rose 16% to $12.98B as strength in energy, railroads and manufacturing offset weaker insurance results. The company accelerated capital deployment, repurchasing about $4.5B of its shares in the quarter and becoming a net buyer of equities with nearly $20B in net purchases, while its cash pile fell to $365.5B from $397.4B. The report also noted a $10B investment in Alphabet earlier this year to help fund AI development, with Berkshire shares up 3% YTD (underperforming the S&P 500).

Analysis

The key market signal is not the earnings print; it is that Berkshire is moving from capital preservation to measured capital recycling. That should put a floor under BRK.B on pullbacks because the company is now a persistent bid for its own stock, and that matters more than a one-quarter earnings beat for valuation support. The second-order effect is a quiet bid to the large-cap quality complex: when Berkshire deploys into public equities, it tends to concentrate in durable franchises and can indirectly support sentiment in AAPL, GOOGL, BAC, AXP and KO without any change in their fundamentals.

The real regime change is capital-allocation optics. If Abel sustains this pace, the bear case that Berkshire is a stagnant cash box weakens and the stock can migrate from "cheap because cash is idle" to "cheap with active internal compounding." The risk is that this is still early and modest versus the cash base, so a single quarter does not prove a new cadence; if buybacks fade again or insurance profitability rolls over, the market will reprice this as temporary.

Contrarian read: the consensus may be overrating the signal to GOOGL. Berkshire buying validates the franchise, but it does not create a near-term earnings catalyst; the actionable impact is multiple support, not a fundamental step-change. The more important nuance is that Berkshire's willingness to buy equities again suggests large-cap dispersion can persist longer than expected, and the market may be underestimating how much incremental demand from a patient balance sheet can cushion drawdowns over the next 1-3 months.

Key Decisions for Investors

• Long BRK.B vs SPY for 3-6 months; use any post-print weakness to add. Risk/reward favors a 5-8% relative outperformance if buybacks remain elevated, with thesis failure if Berkshire reverts to minimal repurchases or cash rebuilds next quarter.
• Initiate a modest long GOOGL position on dips or via a 3-6 month call spread; the setup is sentiment and valuation support, not a near-term fundamentals re-rate. Falsify if AI capex compresses FCF guidance or if regulatory risk re-accelerates.
• Watchlist only, not a trade: AAPL/BAC/AXP/KO as passive Berkshire validation beneficiaries. Use them as relative-strength screens versus the S&P; if they lag despite Berkshire support, it argues the market is discounting capital-allocation signaling more than fund-flow impact.